EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Evaluation of the outcome of interferon therapy in chronic hepatitis B infection

Rahmet ÇAYLAN ¹ , Kemalettin AYDIN ¹ , İftihar KÖKSAL ¹ , Recep ÖKSÜZ ¹ , Uğur KOSTAKOĞLU ¹ , Ümit ÇOBANOĞLU ² , Nurucihan ARI ² , Sevim AYDIN ²

Author Affiliation(s)

1.

KTÜ Tıp Fakültesi İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Trabzon

2.

KTÜ Tıp Fakültesi Patoloji Anabilim Dalı ve Histoloji ve Embriyoloji Anabilim Dalı, Trabzon

Turk J Gastroenterol 1999; 10: 0-0

Keywords : Chronic hepatitis B, interferon therapy.

Read: 1647 Published: 25 July 2019

Volume 10, Issue 3, September 1999

Previous Article